Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Alector, Inc.

Alector to Host Two Virtual Research and Development Events Highlighting TREM2 and Progranulin Programs
From Alector, Inc.
Via GlobeNewswire
Tickers ALEC
Alector to Participate in the Stifel Healthcare Conference
From Alector, Inc.
Via GlobeNewswire
Tickers ALEC
Alector Reports Third Quarter 2023 Financial Results and Provides Business Update
From Alector, Inc.
Via GlobeNewswire
Tickers ALEC
Alector Announces Achievement of Target Enrollment in the Pivotal INFRONT-3 Phase 3 Clinical Trial of Latozinemab in Individuals with Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)
From Alector, Inc.
Via GlobeNewswire
Tickers ALEC GSK
Alector Announces Completion of Enrollment in the INVOKE-2 Phase 2 Clinical Trial of AL002, a TREM2 Monoclonal Antibody, in Individuals With Early Alzheimer’s Disease
From Alector, Inc.
Via GlobeNewswire
Tickers ABBV ALEC
Alector to Participate in Upcoming Healthcare Conferences
From Alector, Inc.
Via GlobeNewswire
Tickers ALEC
Alector Reports Second Quarter 2023 Financial Results and Provides Business Update
From Alector, Inc.
Via GlobeNewswire
Tickers ALEC
Alector to Host Mid-Year Earnings Conference Call
From Alector, Inc.
Via GlobeNewswire
Tickers ALEC
Alector to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
From Alector, Inc.
Via GlobeNewswire
Tickers ALEC
Alector Reports First Quarter 2023 Financial Results and Provides Business Update
From Alector, Inc.
Via GlobeNewswire
Tickers ALEC
Alector to Participate in the BofA Securities 2023 Healthcare Conference
From Alector, Inc.
Via GlobeNewswire
Tickers ALEC
Alector to Participate in Upcoming Healthcare Conferences
From Alector, Inc.
Via GlobeNewswire
Tickers ALEC
Alector Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
From Alector, Inc.
Via GlobeNewswire
Tickers ALEC
Alector Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Alector, Inc.
Via GlobeNewswire
Tickers ALEC
Alector Presents Results from First-in-Human Phase 1 Study of AL101 for the Treatment of Neurodegenerative Diseases
From Alector, Inc.
Via GlobeNewswire
Tickers ALEC
Alector Reports Third Quarter 2022 Financial Results and Provides Business Update
From Alector, Inc.
Via GlobeNewswire
Tickers ALEC
Alector to Participate in Upcoming Healthcare Conferences
From Alector, Inc.
Via GlobeNewswire
Tickers ALEC
Alector Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Alector, Inc.
Via GlobeNewswire
Tickers ALEC
Alector Announces Promotion of Clare Hunt to Chief People Officer
From Alector, Inc.
Via GlobeNewswire
Tickers ALEC
Alector Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Alector, Inc.
Via GlobeNewswire
Tickers ALEC
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.